CNS Pharma surges 27% after hours, adds to 243% regular session rally

CNS Pharmaceuticals

14/04/2023 22:23

** Shares in clinical stage pharma company CNS Pharmaceuticals
Inc  CNSP.O  up 27% in after the bell trading following a 243%
gain in regular session trading that showed record trading
volumes 
    ** Shares in the company, which is working on candidates for
treating brain and nervous system cancers, last traded at ~$3.00
after closing Friday's session at $2.35 
    ** The stock had closed at $0.68 on Thursday
    ** Turnover for Friday exceeded $90 mln for CNSP, which has
2.2 mln shares outstanding and a market cap of $5 mln as of
Friday's close, per Refinitiv
    ** More than 46 mln shares had changed hands so far on
Friday compared with 50-day moving average of 338,812  
    ** Co did not respond to requests for comment. Its latest
announcement, on April 10, was regarding the enrollment of 100
patients in a study of their lead product candidate Berubicin,
for treatment of glioblastoma multiforme    
    ** Stock, which closed 2022 at $2.40, had fallen every year
since its 2019 debut 

 (Reporting By Sinéad Carew)
 ((sinead.carew@thomsonreuters.com;))